Trial Profile
A Clinical Pharmacological Study of OPC-41061 [tolvaptan] in the Treatment of Cardiac Edema (Congestive Heart Failure).
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 12 Apr 2018
Price :
$35
*
At a glance
- Drugs Tolvaptan (Primary)
- Indications Heart failure
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics; Registrational; Therapeutic Use
- Sponsors Otsuka Pharmaceutical
- 16 Dec 2009 Actual end date (Jan 2009) added as reported by ClinicalTrials.gov.
- 16 Dec 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 07 Aug 2008 New trial record.